Jyothy Laboratories Ltd said its normalized net income for the fiscal second quarter ended Sept. 30 came to 1.53 Indian rupees per share, compared with the S&P Capital IQ consensus estimate of 2.16 rupees per share.
EPS rose 76.6% year over year from 87 paise.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 281.9 million rupees, a gain of 79.4% from 157.1 million rupees in the prior-year period.
The normalized profit margin climbed to 7.0% from 4.3% in the year-earlier period.
Total revenue increased 9.0% on an annual basis to 4.01 billion rupees from 3.68 billion rupees, and total operating expenses increased year over year to 3.59 billion rupees from 3.43 billion rupees.
Reported net income rose 54.2% on an annual basis to 387.7 million rupees, or 2.11 rupees per share, from 251.4 million rupees, or 1.39 rupees per share.
As of Oct. 20, US$1 was equivalent to 64.96 Indian rupees.